Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,427,879
+$862,305 QoQ
Shares Held
18,894
+45.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,469
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONECO ADVISORS, LLC holds $43,364,399 across 12 Drug Manufacturers - General names. MRK ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,501 | $16,381,318 | |
| 2 | LLY |
ELI LILLY & Co
|
6,143 | $7,368,099 | |
| 3 | ABBV |
AbbVie Inc.
|
22,944 | $5,773,628 | |
| 4 | PFE |
Pfizer Inc
|
170,546 | $4,106,747 | |
| 5 | GSK |
GSK plc
|
60,767 | $3,185,406 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
18,894 | $2,427,879 | |
| 7 | AMGN |
Amgen Inc
|
4,401 | $1,593,690 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
11,852 | $682,912 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,427,879 | 18,894 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,565,574 | 13,015 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,314,592 | 12,489 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,032,590 | 12,303 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $966,068 | 12,204 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,087,442 | 12,115 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $1,337,707 | 13,447 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $1,232,239 | 10,851 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,389,531 | 11,224 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,530,092 | 11,596 | Shares | Sole | 2024-07-19 | |
| 2023-12-31 | $1,179,487 | 10,819 | Shares | Sole | 2024-03-13 | |
| 2023-09-30 | $1,088,799 | 10,576 | Shares | Sole | 2024-03-13 | |
| 2023-06-30 | $1,157,707 | 10,033 | Shares | Sole | 2024-03-13 | |
| 2023-03-31 | $1,078,475 | 10,137 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $751,575 | 6,774 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $589,233 | 6,842 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $632,902 | 6,942 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $536,032 | 6,533 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $476,164 | 6,213 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $452,612 | 6,026 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $368,240 | 4,735 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $364,096 | 4,723 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $385,523 | 4,713 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $330,638 | 3,986 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $290,296 | 3,754 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $275,983 | 3,587 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||